Experts urge caution: because GLP-1s are powerful drugs, microdosing without proper medical oversight can be risky
Dietary surveys indicate that usual intake among Americans (4 years of age) is 2.2 mg/day
Understanding why fatigue occurs and how to manage it effectively helps patients continue treatment safely while maintaining quality of life
MASH is very common and represents a major public health issue because it increases the risk of liver-related complications, such as cirrhosis and hepatocellular carcinoma, as well as cardiovascular events, chronic kidney disease, type 2 diabetes, extrahepatic cancers, and severe infections
Why people consider GLP-1s: weight loss leads, with clear gender differences Among respondents who currently take, have taken, or would consider taking a GLP-1 (or an alternative), the leading motivation is weight loss: Canada : 58% cite weight loss as a primary reason